The device was not returned for analysis.The lot history record review was not performed because this complaint is based on an article review, and no part or lot information was provided.Based on available information, a cause for the reported atrial perforation could not be determined.The reported hypoxia appears to be a cascading event of the atrial perforation.The reported patient effect of atrial perforation is listed in the instructions for use (ifu) as known possible complications associated with mitraclip procedures.The reported unexpected medical intervention and hospitalization were the results of case-specific circumstances.There is no indication of a product issue with respect to manufacture, design, or labeling.Implant/explant,event and outcomes attributed to adverse event dates estimated.The udi number is not known as the part and lot number were not provided.
|
This is filed to report an atrial septal defect (asd) and hypoxia requiring intervention.It was reported in an article that the patient underwent a mitraclip procedure to treat severe functional mitral regurgitation (mr) and a left atrial appendage closure procedure using a non-abbott device.An xtw mitraclip was successfully implanted on the lateral side of a2-p2 and the procedure was concluded successfully.One day later, a bidirectional iatrogenic asd was recognized due to the patient desaturating during rehabilitation.Four days after the mitraclip procedure, an additional procedure was performed to treat the asd using an amplatzer occluder without reported complication.There was no clinically significant delay in the procedure and no adverse patient sequelae.No additional information was provided.Details are listed in the article titled, "simultaneous procedure of watchman and amplatzer implantation after mitraclip".
|